IDH2 and glioblastoma: Point mutations in the IDH1 or IDH2 gene are correlated with a better overall survival and while they occur frequently in lower-grade astrocytomas (WHO grade II and III) and secondary glioblastomas, they are rare (< 10%) in primary glioblastomas [7].